Month: March 2022

Sorrento Gateway is the latest large-scale project in San Diego with View Smart Windows, following installations at Callan Ridge and The BoardwalkSorrento Gateway in San Diego View announced its Smart Windows will be installed at Sorrento Gateway, a life science building in San Diego under development by Healthpeak Properties, Inc.SAN DIEGO and MILPITAS, Calif., March 24, 2022 (GLOBE NEWSWIRE) — View, Inc. (NASDAQ: VIEW) (“View”), the leader in smart building technologies, announced its Smart Windows will be installed at Sorrento Gateway, a five-story, 163,000-square-foot life science building under development by Healthpeak Properties, Inc. (“Healthpeak”) in conjunction with Project Management Advisors, Inc. (“PMA”), Healthpeak’s representative responsible for providing project management services. Located in San Diego’s...

CHICAGO and VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries, is expanding its partnership with Olive-Harvey College by donating $200,000 to support the school’s cannabis education program. The program provides training, scholarships, equipment, staffing and industry access to help create a more diverse workforce within the cannabis industry. Olive-Harvey is a community college on the southeast side of Chicago and is part of the City Colleges of Chicago. The donation was made on behalf of Green Thumb’s Growing for Good social impact program and fulfills the Company’s Social Equity Inclusion plan requirement for Illinois’ early approval adult-use cultivation...

BOSTON, March 24, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer will participate in two upcoming virtual investor conferences in March:H.C. Wainwright Gene Therapy and Gene Editing ConferencePre-recorded presentation available for on-demand viewing on Wednesday, March 30 at 7:00 a.m. EST. Panel discussion titled “Unlocking the path to hearing restoration with gene therapy” on Wednesday, March 30 at 1:00 p.m. EST.Guggenheim Genomic Medicines & Rare Disease Day on Thursday, March 31.Webcasts of the H.C. Wainwright presentation and panel discussion will...

ACTON, Mass., March 24, 2022 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Kenneth Fisher, CPA, has joined the Company as Chief Financial Officer (CFO), effective March 23, 2022. He will report to Neil Dey, Chief Executive Officer. Gordon Kinder resigned his position as CFO to pursue other professional interests. Mr. Fisher is an accomplished financial professional and Certified Public Accountant. He has enjoyed a 20-year, multi-faceted career in the public accounting and financial services industries. Most recently, he was a senior executive with a $6.6 billion NASDAQ-listed financial institution. Mr. Fisher...

GREENWICH, Conn., March 24, 2022 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading provider of freight transportation services, has been named a Supplier of the Year by General Motors in the transportation category. XPO is among a prestigious group of suppliers recognized by GM executives for outstanding performance in 2021. This is the fourth consecutive year that XPO has been honored as a GM Supplier of the Year. The two companies collaborate on the continuous improvement of GM’s aftermarket parts distribution channel, with a focus on on-time delivery and cost efficiency. Drew Wilkerson, XPO’s president of North American transportation, said, “We’re proud to support General Motors by optimizing the flow of aftermarket parts with an engineered transportation network. Our technology maintains constant visibility of...

Image 1 Copperstone Underground Drill Stations P2E & P2F Panel 2 in Zone D – Looking SouthwestVANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Sabre Gold Mines Corp. (TSX: SGLD, OTCQB: SGLDF) (“Sabre Gold” or the “Company”) is pleased to announce continued positive underground drilling results at its 100% owned Copperstone gold project located in Arizona, United States. Mike Maslowski, Vice President of Technical Services and Exploration of Sabre Gold stated: “Results from what was known as the northern edge of the D zone continue to return high grade gold intercepts. The gold grades and continuity of the intercepts indicates the D Zone may extend further north. We are planning future underground development to establish additional drill stations to the north to test for the extension of this zone.” Drilling...

Lead oncology candidate HB-200 demonstrated high antigen-specific T cell responses and encouraging anti-tumor activity in heavily pre-treated head and neck cancer patientsHOOKIPA received FDA Fast Track designation and advanced HB-200 to Phase 2 trial in combination with pembrolizumab, with data anticipated in H2 2022HOOKIPA and Gilead agreed to advance partnered HIV program, triggering $54 million commitment from GileadStrong 2021 year-end pro forma cash position of $156.9 million when giving effect to payments received in Q1 2022 from Gilead transaction and proceeds of $75 million public follow-on offeringNEW YORK and VIENNA, Austria, March 24, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today...

SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that the Company’s fourth quarter and full year 2021 financial results will be released on Thursday, March 31, 2022. Company management will host a conference call on Thursday, March 31, 2021 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. The press release and live audio webcast can be accessed via the Investor section of the Company’s website at www.calithera.com. The call may be accessed by dialing (855) 783-2599 (domestic) or (631) 485-4877 (international) and referring to conference ID 9989324. Please log in approximately 5-10 minutes before the event to ensure a timely...

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to announce that its partner Golden Arrow Resources Corporation (“Golden Arrow”) has initiated a maiden diamond drilling program at the Libanesa silver-gold project (“Libanesa”) in Santa Cruz province, Argentina. Up to 2,000m of drilling will be completed in eighteen holes ranging from 75 to 250m in depth to test the Cerro Redondo, Lagunita and Lagunita West prospects. Mirasol’s President Tim Heenan commented: “We are pleased by the fast progress from our partner at Libanesa. Their surface work has confirmed and refined the drill targets previously delineated by Mirasol as well as identifying new prospective targets.” Libanesa is a 14,500-hectare silver-gold (lead) project located...

BOSTON and LONDON, March 24, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company will host a conference call and live webcast on Wednesday, March 30, 2022, at 8:00 a.m. ET to review business updates and its fourth quarter and fiscal year 2021 financial results. A live webcast will be available under “News & Events” in the Investors & Media section of the company’s website at www.orchard-tx.com. The conference call can be accessed by dialing (866) 987-6504 (U.S. domestic) or +1 (602) 563-8620 (international) and referring to conference ID 9445456. A replay of the webcast will be archived on the Orchard website following the presentation. About Orchard Therapeutics At Orchard Therapeutics, our vision is to end the devastation caused...